Medical and Pharmaceutical

Neurology Centre of Toronto in Forest Hill expands its therapy catalogue

Eastman's aim is circularity, and collaborations like help change the industry, using molecular recycling to promote a circular healthcare economy.

Liver, lung and breast cancer were the three most prevalent cancers in Vietnam in 2020, according to the World Health Organization.

Application follows successful pre-clinical animal studies at the University of Arkansas

Flagship product from company's medical cannabis division now set for clinical trial use

Cannabinoid tablet supplier expands its Canadian distribution network

Here's a bird's eye view of the sleep technology industry.

Breast cancer is the second most common cancer among women.

Starseed Medicinal services' patient base grew over 50 per cent since 2019

The platform has been launched in Germany, France, the United Kingdom and Portugal

Its Psilly brand wants to offer functional mushroom blends, gummies and chocolates.

Clinical psychedelic sector value anticipated to ascend significantly into 2028

Impending market consolidation set to boost sales of CBD animal products across continent

This April, Pure Extracts Manufacturing Corp. received an IPO from the Nova Scotia Liquor Corporation Cannabis for its vapes and hemp-based edibles

High-grade extract creams now available at participating franchise locations in the U.S.

The company also finished acquiring 51 per cent of CannaCare Health GmbH

New academic journal spotlights potential for rare cannabinoids to treat skin conditions

Novamind's clinics in Utah and Arizona will continue to operate as their current brand until later this year

Dimethyltryptamine continues to demonstrate tremendous therapeutic potential

D9-THCV one of many in company cannabinoid portfolio set to diversify and expand in coming years

Water-soluble cannabinoids provide wide-range of health benefits

More products under the IQANNA brand are expected to be introduced in the coming weeks

62% of respondents said they rather use cannabis than pharmaceuticals when treating a medical issue

The 50mg bottle contains 30mg of CBN and 10mg of THC per mg

The study was the largest of its kind to date, examining the impact of medical cannabis on anxiety and depression in 7,362 Canadian patients

Canadian company set to focus clinical trials down under, announces regulatory update

Many distributors are choosing not to test their products for microbes, pesticides and heavy metals

NOYA produces brands such as Cookies, Lemonnade, Minntz and GAGE

The aim is to expand the evidence base on psilocybin-assisted psychotherapy to inform practical policies and regulations

Curaleaf currently operates in 23 states and has 130 dispensaries

The company's products will specifically be offered to patients undergoing cancer and neurological treatments

The first smart machine is expected to pop up in June 2022

Mac 1 is the first Canadian cannabis product to enter the European market via the Cantourage platform

The oil is now available at the Jardin, Vegas Tree House, and Exhale pot shops in Las Vegas

The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds

But whether or not the disruption helps with the substance's antidepressant properties still needs further research

Since opening in March, the firm says its clinic has already seen 800 patients

The company is also launching a roll-on product for symptom relief